Skip to content

Effect of percutaneous electrical stimulation on the quality of postoperative recovery and inflammatory response in patients undergoing nasal endoscopic surgery: a prospective, randomized controlled clinical trial

Effect of percutaneous electrical stimulation on the quality of postoperative recovery and inflammatory response in patients undergoing nasal endoscopic surgery: a prospective, randomized controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200057129
Enrollment
Unknown
Registered
2022-02-28
Start date
2022-02-28
Completion date
Unknown
Last updated
2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Experimental group:Transcutaneous electrical acupoint stimulation

Sponsors

Xuzhou Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 18 and 60 years; 2. Undergo elective endoscopic nasal surgery; 3. ASA Assessment System level 1-2; 4. Education level at least primary school level or above, mainly able to fully understand and answer the questions in QoR-15 scale; 5. Agree to participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Contraindications to TEAS (scars or skin lesions at the site of irritation, infection, electronic devices such as cardiac pacemakers or other implanted medical electronic devices); 2. Cognitive dysfunction and poor compliance; 3. Severe hearing or vision impairment and inability to read or aphasia; 4. The patient has neuropsychiatric abnormalities, confusion and inability to communicate normally; 5. Abnormal blood coagulation, liver and renal function; 6. Patients with severe cardiovascular disease, sinus bradycardia, atrioventricular block of degree II or higher, and severe arrhythmia; 7. Severe respiratory insufficiency; 8. Those who are not willing to take TEAS and cannot cooperate to complete the questionnaire.

Design outcomes

Primary

MeasureTime frame
Quality of Recovery-15(QoR-15);Inflammatory factor levels;

Secondary

MeasureTime frame
Visual analogue scale (VAS);Intraoperative blood pressure and heart rate;Ramsay Sedation Scale;Analgesic pump usage;Nausea and vomiting;

Countries

China

Contacts

Public ContactWang Liwei

Xuzhou Central Hospital

18952170255@163.com+86 18952170255

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026